CL
COLGATE PALMOLIVE CO
Company overview
- Market capitalization
- $68.97B
- Employees
- 33,600
- Latest publication
- 2026-09-29
About COLGATE PALMOLIVE CO
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline, and Suavitel brands to a range of traditional and eCommerce retailers, wholesalers, and distributors, as well as dentists and skin health professionals. It also offers pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand; and a fresh pet food sold to pet specialty and other retailers in Australia under Prime100 brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q4 20082008-12-31 · USD | Q2 20082008-06-30 · USD | Q1 20082008-03-31 · USD | Q1 19991999-03-31 · USD | Q4 19961996-12-31 · USD | Q3 19961996-09-30 · USD | Q4 19951995-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 5,361,000,000USD | 3,664,100,000USD | 3,964,800,000USD | 3,713,000,000USD | 2,175,300,000USD | 2,297,400,000USD | 2,230,600,000USD | 2,152,800,000USD |
| Cost Of Revenue | 2,065,000,000USD | 1,613,500,000USD | 1,725,000,000USD | 1,613,200,000USD | 1,009,400,000USD | 842,300,000USD | 1,135,800,000USD | 822,000,000USD |
| Gross Profit | 3,296,000,000USD | 2,050,600,000USD | 2,239,800,000USD | 2,099,800,000USD | 1,165,900,000USD | 1,455,100,000USD | 1,094,800,000USD | 1,330,800,000USD |
| Selling General Administrative | 2,130,000,000USD | 1,235,300,000USD | 1,422,700,000USD | 1,348,900,000USD | 801,000,000USD | 738,700,000USD | 799,100,000USD | 694,100,000USD |
| Total Operating Expenses | 2,280,000,000USD | 1,289,000,000USD | 1,472,800,000USD | 1,376,100,000USD | 801,000,000USD | 1,055,000,000USD | 799,100,000USD | 994,400,000USD |
| Operating Income | 1,016,000,000USD | 761,600,000USD | 767,000,000USD | 723,700,000USD | 364,900,000USD | 400,100,000USD | 295,700,000USD | 336,400,000USD |
| Total Other Income Expense Net | -66,000,000USD | -13,600,000USD | -46,800,000USD | -33,700,000USD | -45,900,000USD | -140,600,000USD | -50,400,000USD | -155,600,000USD |
| Interest Income | 17,000,000USD | — | — | — | — | — | — | — |
| Interest Expense | 62,000,000USD | 17,300,000USD | 25,400,000USD | 33,700,000USD | — | — | — | — |
| Income Before Tax | 950,000,000USD | 748,000,000USD | 741,600,000USD | 690,000,000USD | 319,000,000USD | 259,500,000USD | 245,300,000USD | 180,800,000USD |
| Income Tax Expense | 231,000,000USD | 251,000,000USD | 247,800,000USD | 223,500,000USD | 110,100,000USD | 77,800,000USD | 84,400,000USD | 58,300,000USD |
| Net Income | 719,000,000USD | 497,000,000USD | 493,800,000USD | 466,500,000USD | 208,900,000USD | 181,700,000USD | 160,900,000USD | 122,500,000USD |
| Minority Interest | 26,000,000USD | 15,000,000USD | 21,400,000USD | 22,000,000USD | — | — | — | — |
| Net Income Applicable To Common Shares | 693,000,000USD | 489,500,000USD | 486,900,000USD | 459,300,000USD | — | — | — | — |
| Research Development | — | 253,100,000USD | 0USD | 0USD | — | — | — | — |
| Unclassified Operating Expenses | — | -199,400,000USD | 50,100,000USD | 27,200,000USD | — | 316,300,000USD | — | 300,300,000USD |
| Net Income From Continuing Ops | — | 0USD | 0USD | 0USD | — | — | — | — |
| Ebit | — | 771,600,000USD | 788,400,000USD | 745,700,000USD | 364,900,000USD | 282,400,000USD | 295,700,000USD | 244,600,000USD |
| Ebitda | — | 858,300,000USD | 872,200,000USD | 834,300,000USD | 364,900,000USD | 400,100,000USD | 295,700,000USD | 336,400,000USD |
| Depreciation And Amortization | — | 86,700,000USD | 83,800,000USD | 88,600,000USD | -8,100,000USD | 117,700,000USD | -9,400,000USD | 91,800,000USD |
| Reconciled Depreciation | — | 86,700,000USD | 83,800,000USD | 88,600,000USD | — | — | — | — |
| Discontinued Operations | — | 0USD | 0USD | 0USD | — | — | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20032003-12-31 · USD | FY 20022002-12-31 · USD | FY 20012001-12-31 · USD | FY 20002000-12-31 · USD | FY 19991999-12-31 · USD | FY 19981998-12-31 · USD | FY 19971997-12-31 · USD | FY 19961996-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 9,903,400,000USD | 9,294,300,000USD | 9,427,800,000USD | 9,357,900,000USD | 9,118,200,000USD | 8,971,600,000USD | 9,056,700,000USD | 8,749,000,000USD |
| Cost Of Revenue | 4,456,100,000USD | 4,224,200,000USD | 4,236,900,000USD | 4,265,500,000USD | 3,883,800,000USD | 3,960,000,000USD | 4,141,600,000USD | 4,134,800,000USD |
| Gross Profit | 5,447,300,000USD | 5,070,100,000USD | 5,190,900,000USD | 5,092,400,000USD | 5,234,400,000USD | 5,011,600,000USD | 4,915,100,000USD | 4,614,200,000USD |
| Research Development | 204,800,000USD | 196,600,000USD | 184,900,000USD | 176,100,000USD | — | — | — | — |
| Selling General Administrative | 3,296,300,000USD | 3,034,000,000USD | 3,261,600,000USD | 3,299,600,000USD | 3,254,400,000USD | 3,197,100,000USD | 3,237,000,000USD | 3,052,100,000USD |
| Unclassified Operating Expenses | -279,100,000USD | -173,600,000USD | -116,900,000USD | -104,000,000USD | 340,200,000USD | 330,300,000USD | 319,900,000USD | 316,300,000USD |
| Total Operating Expenses | 3,222,000,000USD | 3,057,000,000USD | 3,329,600,000USD | 3,371,700,000USD | 3,594,600,000USD | 3,527,400,000USD | 3,556,900,000USD | 3,368,400,000USD |
| Operating Income | 2,166,000,000USD | 2,013,100,000USD | 1,861,300,000USD | 1,720,700,000USD | 1,639,800,000USD | 1,484,200,000USD | 1,358,200,000USD | 1,245,800,000USD |
| Interest Expense | 0USD | 0USD | 2,021,000,000USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Income Before Tax | 2,041,900,000USD | 1,870,300,000USD | 1,668,700,000USD | 1,567,200,000USD | 1,394,600,000USD | 1,250,100,000USD | 1,102,300,000USD | 954,600,000USD |
| Income Tax Expense | 620,600,000USD | 582,000,000USD | 522,100,000USD | 503,400,000USD | 457,300,000USD | 401,500,000USD | 361,900,000USD | 319,600,000USD |
| Net Income | 1,421,300,000USD | 1,288,300,000USD | 1,146,600,000USD | 1,063,800,000USD | 937,300,000USD | 848,600,000USD | 740,400,000USD | 635,000,000USD |
| Ebit | 2,153,100,000USD | 2,013,100,000USD | 1,834,800,000USD | 1,740,500,000USD | 1,639,800,000USD | 1,484,200,000USD | 1,358,200,000USD | 1,245,800,000USD |
| Ebitda | 2,468,600,000USD | 2,309,600,000USD | 2,171,000,000USD | 2,078,300,000USD | 1,980,000,000USD | 1,814,500,000USD | 1,678,100,000USD | 1,562,100,000USD |
| Depreciation And Amortization | 315,500,000USD | 296,500,000USD | 336,200,000USD | 337,800,000USD | 340,200,000USD | 330,300,000USD | 319,900,000USD | 316,300,000USD |
| Total Other Income Expense Net | -124,100,000USD | -142,800,000USD | -166,100,000USD | -173,300,000USD | -245,200,000USD | -234,100,000USD | -255,900,000USD | -291,200,000USD |
| Minority Interest | 45,200,000USD | 41,300,000USD | 40,100,000USD | 32,600,000USD | — | — | — | — |
| Net Income Applicable To Common Shares | 1,395,600,000USD | 1,266,400,000USD | 1,124,900,000USD | 1,043,100,000USD | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 16,790,000,000USD | 16,610,000,000USD | 16,330,000,000USD | 17,513,000,000USD | 17,470,000,000USD | 16,647,000,000USD | 16,046,000,000USD | 16,774,000,000USD |
| Cash And Equivalents | 1,370,000,000USD | — | 1,288,000,000USD | 1,279,000,000USD | 1,215,000,000USD | 1,112,000,000USD | 1,096,000,000USD | 1,234,000,000USD |
| Total Current Assets | 6,308,000,000USD | 6,082,000,000USD | 5,709,000,000USD | 6,039,000,000USD | 5,996,000,000USD | 5,814,000,000USD | 5,317,000,000USD | 5,806,000,000USD |
| Other Current Assets | 795,000,000USD | 688,000,000USD | 714,000,000USD | 651,000,000USD | 691,000,000USD | 653,000,000USD | 553,000,000USD | 559,000,000USD |
| Other Non Current Assets | 1,027,000,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 16,224,000,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 6,148,000,000USD | 5,934,000,000USD | 5,736,000,000USD | 6,496,000,000USD | 6,775,000,000USD | 6,861,000,000USD | 5,759,000,000USD | 5,565,000,000USD |
| Other Non Current Liabilities | 2,052,000,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 236,000,000USD | 145,000,000USD | 365,000,000USD | 1,238,000,000USD | 1,052,000,000USD | 733,000,000USD | 544,000,000USD | 836,000,000USD |
| Total Equity Including Noncontrolling Interest | 566,000,000USD | — | — | — | — | — | — | — |
| Short Long Term Debt | 7,857,000,000USD | 36,000,000USD | 1,117,000,000USD | 1,113,000,000USD | 1,614,000,000USD | 1,698,000,000USD | 660,000,000USD | 527,000,000USD |
| Long Term Debt | 7,823,000,000USD | 7,937,000,000USD | 6,871,000,000USD | 7,306,000,000USD | 7,144,000,000USD | 6,571,000,000USD | 7,289,000,000USD | 7,909,000,000USD |
| Net Receivables | 1,962,000,000USD | 1,889,000,000USD | 1,675,000,000USD | 1,807,000,000USD | 1,773,000,000USD | 1,725,000,000USD | 1,521,000,000USD | 1,712,000,000USD |
| Inventory | 2,181,000,000USD | 2,086,000,000USD | 2,032,000,000USD | 2,109,000,000USD | 2,120,000,000USD | 2,125,000,000USD | 1,987,000,000USD | 2,041,000,000USD |
| Property Plant Equipment Net | 4,639,000,000USD | 4,622,000,000USD | 4,660,000,000USD | 4,560,000,000USD | 4,529,000,000USD | 4,416,000,000USD | 4,422,000,000USD | 4,421,000,000USD |
| Goodwill | 3,100,000,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 1,495,000,000USD | 1,521,000,000USD | 1,536,000,000USD | 1,889,000,000USD | 1,904,000,000USD | 1,782,000,000USD | 1,756,000,000USD | 1,834,000,000USD |
| Accounts Payable | 2,115,000,000USD | 2,096,000,000USD | 2,089,000,000USD | 1,866,000,000USD | 1,790,000,000USD | 1,800,000,000USD | 1,805,000,000USD | 1,625,000,000USD |
| Short Term Debt | 34,000,000USD | 36,000,000USD | 1,235,000,000USD | 1,113,000,000USD | 1,614,000,000USD | 1,698,000,000USD | 767,000,000USD | 527,000,000USD |
| Common Stock | 1,466,000,000USD | 1,466,000,000USD | 1,466,000,000USD | 1,466,000,000USD | 1,466,000,000USD | 1,466,000,000USD | 1,466,000,000USD | 1,466,000,000USD |
| Retained Earnings | 27,085,000,000USD | 26,816,000,000USD | 26,595,000,000USD | 27,051,000,000USD | 26,735,000,000USD | 26,413,000,000USD | 26,145,000,000USD | 25,814,000,000USD |
| Accumulated Other Comprehensive Income | -3,816,000,000USD | -3,871,000,000USD | -3,879,000,000USD | -3,888,000,000USD | -3,924,000,000USD | -4,116,000,000USD | -4,222,000,000USD | -4,074,000,000USD |
| Total Liab | — | 16,124,000,000USD | 15,965,000,000USD | 16,275,000,000USD | 16,418,000,000USD | 15,914,000,000USD | 15,502,000,000USD | 15,938,000,000USD |
| Other Current Liab | — | 3,802,000,000USD | 5,736,000,000USD | 3,517,000,000USD | 3,050,000,000USD | 2,873,000,000USD | 2,622,000,000USD | 3,066,000,000USD |
| Capital Stock | — | 1,466,000,000USD | 1,466,000,000USD | 1,466,000,000USD | 1,466,000,000USD | 1,466,000,000USD | 1,466,000,000USD | 1,466,000,000USD |
| Good Will | — | 3,107,000,000USD | 3,122,000,000USD | 3,702,000,000USD | 3,696,000,000USD | 3,334,000,000USD | 3,272,000,000USD | 3,389,000,000USD |
| Cash | — | 1,335,000,000USD | 1,288,000,000USD | 1,279,000,000USD | 1,215,000,000USD | 1,112,000,000USD | 1,096,000,000USD | 1,234,000,000USD |
| Cash And Short Term Investments | — | 1,419,000,000USD | 1,288,000,000USD | 1,472,000,000USD | 1,412,000,000USD | 1,311,000,000USD | 1,256,000,000USD | 1,494,000,000USD |
| Net Debt | — | 6,638,000,000USD | 6,700,000,000USD | 7,140,000,000USD | 7,543,000,000USD | 7,157,000,000USD | 7,416,000,000USD | 7,202,000,000USD |
| Short Long Term Debt Total | — | 7,973,000,000USD | 8,554,000,000USD | 8,419,000,000USD | 8,758,000,000USD | 8,269,000,000USD | 8,512,000,000USD | 8,436,000,000USD |
| Short Term Investments | — | 84,000,000USD | 107,000,000USD | 193,000,000USD | 197,000,000USD | 199,000,000USD | 160,000,000USD | 260,000,000USD |
| Property Plant Equipment Gross | — | 10,887,000,000USD | 10,856,000,000USD | 10,847,000,000USD | 10,665,000,000USD | 10,276,000,000USD | 10,127,000,000USD | 10,238,000,000USD |
| Common Stock Shares Outstanding | — | 805,100,000shares | 804,700,000shares | 810,200,000shares | 816,484,000shares | 822,500,000shares | 822,500,000shares | 822,500,000shares |
| Non Current Assets Total | — | 10,528,000,000USD | 10,621,000,000USD | 11,474,000,000USD | 11,474,000,000USD | 10,833,000,000USD | 10,729,000,000USD | 10,968,000,000USD |
| Non Current Liabilities Total | — | 10,190,000,000USD | 10,229,000,000USD | 9,779,000,000USD | 9,643,000,000USD | 9,053,000,000USD | 9,743,000,000USD | 10,373,000,000USD |
| Non Current Liabilities Other | — | 2,055,000,000USD | 362,000,000USD | 2,169,000,000USD | 2,220,000,000USD | 2,180,000,000USD | 320,000,000USD | 2,144,000,000USD |
| Non Currrent Assets Other | — | 1,067,000,000USD | 1,303,000,000USD | 1,323,000,000USD | 1,127,000,000USD | 1,090,000,000USD | 1,003,000,000USD | 1,105,000,000USD |
| Net Working Capital | — | 148,000,000USD | -1,144,000,000USD | -457,000,000USD | -779,000,000USD | -1,047,000,000USD | -442,000,000USD | 241,000,000USD |
| Unclassified Non Current Assets | — | 211,000,000USD | -1,303,000,000USD | -1,323,000,000USD | -1,127,000,000USD | -1,090,000,000USD | -1,003,000,000USD | 219,000,000USD |
| Unclassified Non Current Liabilities | — | 198,000,000USD | 2,996,000,000USD | 304,000,000USD | 279,000,000USD | 302,000,000USD | 2,134,000,000USD | 320,000,000USD |
| Unclassified Equity | — | -25,732,000,000USD | -25,283,000,000USD | -24,857,000,000USD | -24,691,000,000USD | -24,496,000,000USD | -24,311,000,000USD | -23,836,000,000USD |
| Other Assets | — | — | 1,303,000,000USD | 1,323,000,000USD | 1,345,000,000USD | 1,301,000,000USD | 1,279,000,000USD | -4,799,000,000USD |
| Unclassified Current Assets | — | — | -107,000,000USD | — | — | — | — | — |
| Unclassified Current Liabilities | — | — | -4,441,000,000USD | -1,113,000,000USD | -1,293,000,000USD | -1,208,000,000USD | -95,000,000USD | -527,000,000USD |
| Current Deferred Revenue | — | — | — | — | — | — | — | 347,000,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 16,330,000,000USD | 16,046,000,000USD | 16,393,000,000USD | 15,731,000,000USD | 15,040,000,000USD | 15,920,000,000USD | 15,034,000,000USD | 12,161,000,000USD |
| Intangible Assets | 1,536,000,000USD | 1,756,000,000USD | 1,887,000,000USD | 1,920,000,000USD | 2,462,000,000USD | 2,894,000,000USD | 2,667,000,000USD | 1,637,000,000USD |
| Other Current Assets | 714,000,000USD | 553,000,000USD | 793,000,000USD | 760,000,000USD | 576,000,000USD | 513,000,000USD | 456,000,000USD | 417,000,000USD |
| Total Liab | 15,965,000,000USD | 15,502,000,000USD | 15,436,000,000USD | 14,925,000,000USD | 14,069,000,000USD | 14,819,000,000USD | 14,476,000,000USD | 11,964,000,000USD |
| Total Stockholder Equity | 365,000,000USD | 544,000,000USD | 957,000,000USD | 806,000,000USD | 971,000,000USD | 1,101,000,000USD | 558,000,000USD | 197,000,000USD |
| Other Current Liab | 5,736,000,000USD | 2,622,000,000USD | 2,115,000,000USD | 1,870,000,000USD | 4,000,000,000USD | 4,137,000,000USD | 3,524,000,000USD | 1,569,000,000USD |
| Common Stock | 1,466,000,000USD | 1,466,000,000USD | 1,466,000,000USD | 1,466,000,000USD | 1,466,000,000USD | 1,466,000,000USD | 1,466,000,000USD | 1,466,000,000USD |
| Capital Stock | 1,466,000,000USD | 1,466,000,000USD | 1,466,000,000USD | 1,466,000,000USD | 1,466,000,000USD | 1,466,000,000USD | 1,466,000,000USD | 1,466,000,000USD |
| Retained Earnings | 26,595,000,000USD | 26,145,000,000USD | 25,289,000,000USD | 24,573,000,000USD | 24,350,000,000USD | 23,699,000,000USD | 22,501,000,000USD | 21,615,000,000USD |
| Good Will | 3,122,000,000USD | 3,272,000,000USD | 3,410,000,000USD | 3,352,000,000USD | 3,284,000,000USD | 3,824,000,000USD | 3,508,000,000USD | 2,530,000,000USD |
| Other Assets | 1,303,000,000USD | 669,000,000USD | 661,000,000USD | 1,039,000,000USD | 1,167,000,000USD | 1,148,000USD | 374,000,000USD | 274,000,000USD |
| Cash | 1,288,000,000USD | 1,096,000,000USD | 966,000,000USD | 775,000,000USD | 832,000,000USD | 888,000,000USD | 883,000,000USD | 726,000,000USD |
| Cash And Equivalents | 1,288,000,000USD | 1,096,000,000USD | 966,000,000USD | 775,000,000USD | 832,000,000USD | 888,000,000USD | 883,000,000USD | 726,000,000USD |
| Cash And Short Term Investments | 1,288,000,000USD | 1,256,000,000USD | 966,000,000USD | 775,000,000USD | 832,000,000USD | 888,000,000USD | 883,000,000USD | 726,000,000USD |
| Total Current Assets | 5,709,000,000USD | 5,317,000,000USD | 5,279,000,000USD | 5,113,000,000USD | 4,397,000,000USD | 4,338,000,000USD | 4,179,000,000USD | 3,793,000,000USD |
| Total Current Liabilities | 5,736,000,000USD | 5,759,000,000USD | 4,741,000,000USD | 4,004,000,000USD | 4,000,000,000USD | 4,137,000,000USD | 11,371,000,000USD | 3,341,000,000USD |
| Net Debt | 6,700,000,000USD | 7,416,000,000USD | 8,098,000,000USD | 8,496,000,000USD | 6,413,000,000USD | 6,713,000,000USD | 6,964,000,000USD | 5,640,000,000USD |
| Short Term Debt | 1,235,000,000USD | 767,000,000USD | 425,000,000USD | 133,000,000USD | 188,000,000USD | 404,000,000USD | 7,847,000,000USD | 12,000,000USD |
| Short Long Term Debt | 1,117,000,000USD | 660,000,000USD | 330,000,000USD | 25,000,000USD | 51,000,000USD | 267,000,000USD | 514,000,000USD | 12,000,000USD |
| Short Long Term Debt Total | 8,554,000,000USD | 8,512,000,000USD | 9,064,000,000USD | 9,271,000,000USD | 7,433,000,000USD | 7,738,000,000USD | 15,180,000,000USD | 6,366,000,000USD |
| Long Term Debt | 6,871,000,000USD | 7,289,000,000USD | 8,219,000,000USD | 8,741,000,000USD | 7,245,000,000USD | 7,334,000,000USD | 7,333,000,000USD | 6,354,000,000USD |
| Short Term Investments | 107,000,000USD | 160,000,000USD | 179,000,000USD | 175,000,000USD | 34,000,000USD | 37,000,000USD | 23,000,000USD | 10,000,000USD |
| Net Receivables | 1,675,000,000USD | 1,521,000,000USD | 1,586,000,000USD | 1,504,000,000USD | 1,297,000,000USD | 1,264,000,000USD | 1,440,000,000USD | 1,400,000,000USD |
| Inventory | 2,032,000,000USD | 1,987,000,000USD | 1,934,000,000USD | 2,074,000,000USD | 1,692,000,000USD | 1,673,000,000USD | 1,400,000,000USD | 1,250,000,000USD |
| Accounts Payable | 2,089,000,000USD | 1,805,000,000USD | 1,698,000,000USD | 1,551,000,000USD | 1,479,000,000USD | 1,393,000,000USD | 1,237,000,000USD | 1,222,000,000USD |
| Property Plant Equipment Net | 4,660,000,000USD | 4,422,000,000USD | 4,582,000,000USD | 4,307,000,000USD | 3,730,000,000USD | 3,716,000,000USD | 3,750,000,000USD | 3,881,000,000USD |
| Property Plant Equipment Gross | 10,856,000,000USD | 10,127,000,000USD | 10,286,000,000USD | 9,583,000,000USD | 8,899,000,000USD | 3,716,000,000USD | 3,750,000,000USD | 3,881,000,000USD |
| Accumulated Other Comprehensive Income | -3,879,000,000USD | -4,222,000,000USD | -3,937,000,000USD | -4,055,000,000USD | -4,386,000,000USD | -4,345,000,000USD | -4,273,000,000USD | -4,188,000,000USD |
| Common Stock Shares Outstanding | 811,100,000shares | 822,500,000shares | 829,200,000shares | 838,800,000shares | 848,300,000shares | 859,300,000shares | 861,100,000shares | 873,000,000shares |
| Non Current Assets Total | 10,621,000,000USD | 10,729,000,000USD | 11,114,000,000USD | 10,618,000,000USD | 10,643,000,000USD | 11,582,000,000USD | 10,855,000,000USD | 8,368,000,000USD |
| Non Current Liabilities Total | 10,229,000,000USD | 9,743,000,000USD | 10,695,000,000USD | 10,921,000,000USD | 10,069,000,000USD | 10,682,000,000USD | 3,105,000,000USD | 8,623,000,000USD |
| Non Current Liabilities Other | 362,000,000USD | 320,000,000USD | 305,000,000USD | 2,180,000,000USD | 2,824,000,000USD | 2,655,000,000USD | 2,598,000,000USD | 2,034,000,000USD |
| Non Currrent Assets Other | 1,303,000,000USD | 1,003,000,000USD | 1,021,000,000USD | 904,000,000USD | 1,167,000,000USD | 1,148,000,000USD | 930,000,000USD | 168,000,000USD |
| Net Working Capital | -1,144,000,000USD | -442,000,000USD | 538,000,000USD | 1,134,000,000USD | 397,000,000USD | -66,000,000USD | 141,000,000USD | 452,000,000USD |
| Unclassified Current Assets | -107,000,000USD | — | -179,000,000USD | -175,000,000USD | — | — | — | — |
| Unclassified Non Current Assets | -1,303,000,000USD | -393,000,000USD | -447,000,000USD | -904,000,000USD | -1,167,000,000USD | — | -428,000,000USD | -168,000,000USD |
| Unclassified Current Liabilities | -4,441,000,000USD | -95,000,000USD | -1,237,000,000USD | 425,000,000USD | -1,718,000,000USD | -2,064,000,000USD | -1,751,000,000USD | — |
| Unclassified Non Current Liabilities | 2,996,000,000USD | 2,134,000,000USD | 2,171,000,000USD | -2,166,000,000USD | -3,219,000,000USD | -2,814,000,000USD | -9,947,000,000USD | -2,261,000,000USD |
| Unclassified Equity | -25,283,000,000USD | -24,311,000,000USD | -23,327,000,000USD | -22,644,000,000USD | 2,164,000,000USD | 1,860,000,000USD | 1,461,000,000USD | 1,034,000,000USD |
| Current Deferred Revenue | — | — | 1,410,000,000USD | — | -1,667,000,000USD | -1,797,000,000USD | -1,237,000,000USD | 538,000,000USD |
| Deferred Long Term Liab | — | — | — | 383,000,000USD | 395,000,000USD | 426,000,000USD | 507,000,000USD | 235,000,000USD |
| Other Liab | — | — | — | 1,783,000,000USD | 2,824,000,000USD | 3,081,000,000USD | 2,614,000,000USD | 2,261,000,000USD |
| Net Tangible Assets | — | — | — | -4,871,000,000USD | -5,137,000,000USD | -5,975,000,000USD | 117,000,000USD | -102,000,000USD |
| Treasury Stock | — | — | — | — | -24,089,000,000USD | -23,045,000,000USD | -22,063,000,000USD | -21,196,000,000USD |
| Long Term Investments | — | — | — | — | — | — | 54,000,000USD | 46,000,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Net Income | 1,401,000,000USD |
| Depreciation | 311,000,000USD |
| Stock Based Compensation | 78,000,000USD |
| Deferred Income Tax | -15,000,000USD |
| Unclassified Operating Cash Flow | 227,000,000USD |
| Change To Account Receivables | -274,000,000USD |
| Change To Inventory | -110,000,000USD |
| Change To Liabilities | 124,000,000USD |
| Change In Working Capital | -260,000,000USD |
| Operating Cash Flow | 1,742,000,000USD |
| Capital Expenditures | -266,000,000USD |
| Net Investments | 26,000,000USD |
| Other Investing Activities | -4,000,000USD |
| Unclassified Investing Cash Flow | 0USD |
| Investing Cash Flow | -244,000,000USD |
| Net Debt Issuance | -33,000,000USD |
| Common Stock Issuance | 138,000,000USD |
| Net Common Stock Issuance | -459,000,000USD |
| Common Dividends Paid | -879,000,000USD |
| Other Financing Activities | -43,000,000USD |
| Unclassified Financing Cash Flow | 0USD |
| Financing Cash Flow | -1,414,000,000USD |
| Effect Of Forex Changes On Cash | -2,000,000USD |
| Change In Cash | 82,000,000USD |
| End Cash Flow | 1,370,000,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 646,000,000USD | -37,000,000USD | 767,000,000USD | 773,000,000USD | 726,000,000USD | 779,000,000USD | 775,000,000USD | 766,000,000USD |
| Depreciation | 156,000,000USD | 173,000,000USD | 158,000,000USD | 151,000,000USD | 148,000,000USD | 148,000,000USD | 150,000,000USD | 157,000,000USD |
| Stock Based Compensation | 40,000,000USD | 28,000,000USD | 72,000,000USD | 32,000,000USD | 23,000,000USD | 27,000,000USD | 65,000,000USD | 24,000,000USD |
| Other Non Cash Items | 240,000,000USD | 987,000,000USD | -2,000,000USD | -6,000,000USD | 58,000,000USD | -3,000,000USD | 6,000,000USD | 18,000,000USD |
| Change To Account Receivables | -215,000,000USD | 164,000,000USD | -28,000,000USD | 22,000,000USD | -174,000,000USD | 128,000,000USD | 125,000,000USD | -57,000,000USD |
| Change To Inventory | -41,000,000USD | 100,000,000USD | 6,000,000USD | 89,000,000USD | -86,000,000USD | -6,000,000USD | -77,000,000USD | -28,000,000USD |
| Change In Working Capital | -277,000,000USD | 447,000,000USD | 241,000,000USD | -73,000,000USD | -331,000,000USD | 297,000,000USD | 177,000,000USD | 129,000,000USD |
| Total Cash From Operating Activities | 747,000,000USD | 1,453,000,000USD | 1,261,000,000USD | 884,000,000USD | 600,000,000USD | 1,269,000,000USD | 1,167,000,000USD | 990,000,000USD |
| Capital Expenditures | -138,000,000USD | -177,000,000USD | -155,000,000USD | -108,000,000USD | -124,000,000USD | -184,000,000USD | -134,000,000USD | -117,000,000USD |
| Free Cash Flow | 609,000,000USD | 1,276,000,000USD | 1,106,000,000USD | 776,000,000USD | 476,000,000USD | 1,085,000,000USD | 1,033,000,000USD | 873,000,000USD |
| Investments | 24,000,000USD | 83,000,000USD | -154,000,000USD | -401,000,000USD | -159,000,000USD | -80,000,000USD | -150,000,000USD | -111,000,000USD |
| Total Cashflows From Investing Activities | -122,000,000USD | -103,000,000USD | -154,000,000USD | -401,000,000USD | -159,000,000USD | -80,000,000USD | -150,000,000USD | -111,000,000USD |
| Net Borrowings | 56,000,000USD | -437,000,000USD | -347,000,000USD | 168,000,000USD | 160,000,000USD | -245,000,000USD | -401,000,000USD | — |
| Total Cash From Financing Activities | -563,000,000USD | -1,361,000,000USD | -1,028,000,000USD | -409,000,000USD | -458,000,000USD | -1,279,000,000USD | -904,000,000USD | -845,000,000USD |
| Dividends Paid | -417,000,000USD | -523,000,000USD | -420,000,000USD | -474,000,000USD | -406,000,000USD | -514,000,000USD | -408,000,000USD | -473,000,000USD |
| Sale Purchase Of Stock | -306,000,000USD | -406,000,000USD | -288,000,000USD | -232,000,000USD | -284,000,000USD | -455,000,000USD | -295,000,000USD | -480,000,000USD |
| Change In Cash | 47,000,000USD | 9,000,000USD | 64,000,000USD | 103,000,000USD | 16,000,000USD | -138,000,000USD | 124,000,000USD | 31,000,000USD |
| Begin Period Cash Flow | 1,288,000,000USD | 1,279,000,000USD | 1,215,000,000USD | 1,112,000,000USD | 1,096,000,000USD | 1,234,000,000USD | 1,110,000,000USD | 1,079,000,000USD |
| End Period Cash Flow | 1,335,000,000USD | 1,288,000,000USD | 1,279,000,000USD | 1,215,000,000USD | 1,112,000,000USD | 1,096,000,000USD | 1,234,000,000USD | 1,110,000,000USD |
| Other Cashflows From Investing Activities | -8,000,000USD | -9,000,000USD | 289,000,000USD | -296,000,000USD | 2,000,000USD | 16,000,000USD | 17,000,000USD | 10,000,000USD |
| Other Cashflows From Financing Activities | -23,000,000USD | -13,000,000USD | 9,000,000USD | 129,000,000USD | 32,000,000USD | -92,000,000USD | 44,000,000USD | -20,000,000USD |
| Unclassified Operating Cash Flow | -58,000,000USD | -145,000,000USD | 25,000,000USD | — | -24,000,000USD | 21,000,000USD | — | -104,000,000USD |
| Unclassified Financing Cash Flow | 127,000,000USD | 18,000,000USD | 18,000,000USD | — | 40,000,000USD | 27,000,000USD | 156,000,000USD | 128,000,000USD |
| Unclassified Investing Cash Flow | — | — | -134,000,000USD | 404,000,000USD | 122,000,000USD | 168,000,000USD | 117,000,000USD | 107,000,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 2,132,000,000USD | 3,049,000,000USD | 2,455,000,000USD | 1,967,000,000USD | 2,338,000,000USD | 2,860,000,000USD | 2,527,000,000USD | 2,558,000,000USD |
| Depreciation | 630,000,000USD | 605,000,000USD | 567,000,000USD | 545,000,000USD | 556,000,000USD | 539,000,000USD | 519,000,000USD | 511,000,000USD |
| Stock Based Compensation | 155,000,000USD | 135,000,000USD | 122,000,000USD | 125,000,000USD | 135,000,000USD | 107,000,000USD | 100,000,000USD | 109,000,000USD |
| Other Non Cash Items | 1,261,000,000USD | 51,000,000USD | 244,000,000USD | 723,000,000USD | 625,000,000USD | -48,000,000USD | -95,000,000USD | -74,000,000USD |
| Change To Account Receivables | -16,000,000USD | -56,000,000USD | -37,000,000USD | -227,000,000USD | -84,000,000USD | 138,000,000USD | 19,000,000USD | -79,000,000USD |
| Change To Inventory | 109,000,000USD | -100,000,000USD | 194,000,000USD | -333,000,000USD | -72,000,000USD | -251,000,000USD | -77,000,000USD | -58,000,000USD |
| Change In Working Capital | 284,000,000USD | 344,000,000USD | 455,000,000USD | -726,000,000USD | -197,000,000USD | 381,000,000USD | 65,000,000USD | -155,000,000USD |
| Total Cash From Operating Activities | 4,198,000,000USD | 4,107,000,000USD | 3,745,000,000USD | 2,556,000,000USD | 3,325,000,000USD | 3,719,000,000USD | 3,133,000,000USD | 3,056,000,000USD |
| Capital Expenditures | -564,000,000USD | -561,000,000USD | -705,000,000USD | -696,000,000USD | -567,000,000USD | -410,000,000USD | -335,000,000USD | -436,000,000USD |
| Free Cash Flow | 3,634,000,000USD | 3,546,000,000USD | 3,040,000,000USD | 1,860,000,000USD | 2,758,000,000USD | 3,309,000,000USD | 2,798,000,000USD | 2,620,000,000USD |
| Investments | 54,000,000USD | -534,000,000USD | -772,000,000USD | -1,601,000,000USD | -592,000,000USD | -19,000,000USD | -53,000,000USD | -13,000,000USD |
| Total Cashflows From Investing Activities | -817,000,000USD | -534,000,000USD | -742,000,000USD | -1,601,000,000USD | -592,000,000USD | -779,000,000USD | -2,099,000,000USD | -1,170,000,000USD |
| Net Borrowings | -456,000,000USD | -408,000,000USD | -314,000,000USD | 1,647,000,000USD | -175,000,000USD | -564,000,000USD | 1,448,000,000USD | -179,000,000USD |
| Total Cash From Financing Activities | -3,256,000,000USD | -3,389,000,000USD | -2,793,000,000USD | -952,000,000USD | -2,774,000,000USD | -2,919,000,000USD | -870,000,000USD | -2,679,000,000USD |
| Dividends Paid | -1,823,000,000USD | -1,789,000,000USD | -1,749,000,000USD | -1,691,000,000USD | -1,679,000,000USD | -1,654,000,000USD | -1,614,000,000USD | -1,591,000,000USD |
| Sale Purchase Of Stock | -1,210,000,000USD | -1,739,000,000USD | -1,128,000,000USD | -1,308,000,000USD | -1,320,000,000USD | -1,476,000,000USD | -1,202,000,000USD | -1,238,000,000USD |
| Change In Cash | 192,000,000USD | 130,000,000USD | 191,000,000USD | -57,000,000USD | -56,000,000USD | 5,000,000USD | 157,000,000USD | -809,000,000USD |
| Begin Period Cash Flow | 1,096,000,000USD | 966,000,000USD | 775,000,000USD | 832,000,000USD | 888,000,000USD | 883,000,000USD | 726,000,000USD | 1,535,000,000USD |
| End Period Cash Flow | 1,288,000,000USD | 1,096,000,000USD | 966,000,000USD | 775,000,000USD | 832,000,000USD | 888,000,000USD | 883,000,000USD | 726,000,000USD |
| Other Cashflows From Investing Activities | -14,000,000USD | 37,000,000USD | -33,000,000USD | -905,000,000USD | -25,000,000USD | -350,000,000USD | -1,711,000,000USD | 7,000,000USD |
| Other Cashflows From Financing Activities | 132,000,000USD | 547,000,000USD | 398,000,000USD | 2,453,000,000USD | -24,000,000USD | -99,000,000USD | 8,557,000,000USD | 329,000,000USD |
| Unclassified Operating Cash Flow | -264,000,000USD | -77,000,000USD | -98,000,000USD | -78,000,000USD | -132,000,000USD | -120,000,000USD | — | 107,000,000USD |
| Unclassified Investing Cash Flow | -293,000,000USD | 524,000,000USD | 768,000,000USD | 1,601,000,000USD | 592,000,000USD | — | — | -728,000,000USD |
| Unclassified Financing Cash Flow | 101,000,000USD | — | — | -2,053,000,000USD | 424,000,000USD | 874,000,000USD | -8,059,000,000USD | — |
| Change To Liabilities | — | — | — | -115,000,000USD | 14,000,000USD | 520,000,000USD | 36,000,000USD | 18,000,000USD |
| Cash And Cash Equivalents Changes | — | — | — | 3,000,000USD | -41,000,000USD | 21,000,000USD | 164,000,000USD | -809,000,000USD |
| Exchange Rate Changes | — | — | — | — | — | — | — | -16,000,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
Advertising Investment
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 777,000,000 | USD | Disclosure |
Advertising Investment YTD
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | year_to_date | 1,511,000,000 | USD | Disclosure |
Advertising Investment as a Percentage of Net Sales
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 14.5 | percent | Disclosure |
Advertising Investment as a Percentage of Net Sales YTD
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | year_to_date | 14.1 | percent | Disclosure |
Asia Pacific Net Selling Price Change
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 1.1 | percent | Disclosure |
Asia Pacific Net Selling Price Change YTD
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | year_to_date | 1.1 | percent | Disclosure |
Asia Pacific Volume Growth
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 4.1 | percent | Disclosure |
Asia Pacific Volume Growth YTD
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | year_to_date | 4.3 | percent | Disclosure |
EMEA Net Selling Price Change
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | -1.2 | percent | Disclosure |
EMEA Net Selling Price Change YTD
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | year_to_date | 0 | percent | Disclosure |
EMEA Volume Growth
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 3.2 | percent | Disclosure |
EMEA Volume Growth YTD
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | year_to_date | 2.7 | percent | Disclosure |
Global Manual Toothbrush Market Share
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | year_to_date | 32.7 | percent | Disclosure |
Global Toothpaste Market Share
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | year_to_date | 41.3 | percent | Disclosure |
Hill's Pet Nutrition Net Selling Price Change
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 3.9 | percent | Disclosure |
Hill's Pet Nutrition Net Selling Price Change YTD
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | year_to_date | 3.9 | percent | Disclosure |
Hill's Pet Nutrition Volume Growth
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | -1.2 | percent | Disclosure |
Hill's Pet Nutrition Volume Growth YTD
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | year_to_date | -0.5 | percent | Disclosure |
Latin America Net Selling Price Change
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 2.8 | percent | Disclosure |
Latin America Net Selling Price Change YTD
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | year_to_date | 3.1 | percent | Disclosure |
Latin America Volume Growth
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 2.6 | percent | Disclosure |
Latin America Volume Growth YTD
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | year_to_date | 2.3 | percent | Disclosure |
North America Net Selling Price Change
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 0.9 | percent | Disclosure |
North America Net Selling Price Change YTD
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | year_to_date | 0.9 | percent | Disclosure |
North America Volume Growth
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | -3.9 | percent | Disclosure |
North America Volume Growth YTD
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | year_to_date | -3.6 | percent | Disclosure |
Oral, Personal and Home Care Net Selling Price Change
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 0.9 | percent | Disclosure |
Oral, Personal and Home Care Net Selling Price Change YTD
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | year_to_date | 1.3 | percent | Disclosure |
Oral, Personal and Home Care Volume Growth
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 1.5 | percent | Disclosure |
Oral, Personal and Home Care Volume Growth YTD
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | year_to_date | 1.4 | percent | Disclosure |
Working Capital as a Percentage of Net Sales
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | -5.9 | percent | Disclosure |
Worldwide Net Selling Price Change
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 1.6 | percent | Disclosure |
Worldwide Net Selling Price Change YTD
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | year_to_date | 1.9 | percent | Disclosure |
Worldwide Volume Growth
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 0.9 | percent | Disclosure |
Worldwide Volume Growth YTD
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | year_to_date | 1 | percent | Disclosure |
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Segment | Hills Pet Nutrition | 1,195,000,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Segment | Oral Personal And Home Care | 4,166,000,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Segment | Hills Pet Nutrition | 1,194,000,000 | USD | 0000021665-26-000023 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Oral Personal And Home Care | 4,131,000,000 | USD | 0000021665-26-000023 |
| Q4 2025Quarterly · 2025-12-31 | Segment | Oral Personal And Home Care | 4,034,000,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Pet Nutrition | 1,196,000,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Segment | Oral Personal And Home Care | 15,769,000,000 | USD | 0000021665-26-000006 |
| FY 2025Yearly · 2025-12-31 | Segment | Pet Nutrition | 4,613,000,000 | USD | 0000021665-26-000006 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Oral Personal And Home Care | 3,989,000,000 | USD | 0000021665-25-000053 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Pet Nutrition | 1,142,000,000 | USD | 0000021665-25-000053 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Oral Personal And Home Care | 3,954,000,000 | USD | 0000021665-25-000041 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Pet Nutrition | 1,157,000,000 | USD | 0000021665-25-000041 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Hills Pet Nutrition | 1,118,000,000 | USD | 0000021665-26-000023 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Oral Personal And Home Care | 3,792,000,000 | USD | 0000021665-26-000023 |
| Q4 2024Quarterly · 2024-12-31 | Segment | Oral Personal And Home Care | 3,804,000,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Pet Nutrition | 1,141,000,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Segment | Oral Personal And Home Care | 15,618,000,000 | USD | 0000021665-26-000006 |
| FY 2024Yearly · 2024-12-31 | Segment | Pet Nutrition | 4,483,000,000 | USD | 0000021665-26-000006 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Oral Personal And Home Care | 3,907,000,000 | USD | 0000021665-25-000053 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Pet Nutrition | 1,126,000,000 | USD | 0000021665-25-000053 |
| FY 2023Yearly · 2023-12-31 | Segment | Oral Personal And Home Care | 15,167,000,000 | USD | 0000021665-26-000006 |
| FY 2023Yearly · 2023-12-31 | Segment | Pet Nutrition | 4,290,000,000 | USD | 0000021665-26-000006 |
| FY 2022Yearly · 2022-12-31 | Segment | Oral Personal And Home Care | 14,254,000,000 | USD | 0000021665-25-000008 |
| FY 2022Yearly · 2022-12-31 | Segment | Pet Nutrition | 3,713,000,000 | USD | 0000021665-25-000008 |
| FY 2021Yearly · 2021-12-31 | Segment | Oral Personal And Home Care | 14,110,000,000 | USD | 0000021665-24-000003 |
| FY 2021Yearly · 2021-12-31 | Segment | Pet Nutrition | 3,311,000,000 | USD | 0000021665-24-000003 |
| FY 2020Yearly · 2020-12-31 | Segment | Oral Personal And Home Care | 13,588,000,000 | USD | 0000021665-23-000007 |
| FY 2020Yearly · 2020-12-31 | Segment | Pet Nutrition | 2,883,000,000 | USD | 0000021665-23-000007 |
| FY 2019Yearly · 2019-12-31 | Segment | Oral Personal And Home Care | 13,168,000,000 | USD | 0000021665-22-000003 |
| FY 2019Yearly · 2019-12-31 | Segment | Pet Nutrition | 2,525,000,000 | USD | 0000021665-22-000003 |
| FY 2018Yearly · 2018-12-31 | Segment | Oral Personal And Home Care | 13,156,000,000 | USD | 0000021665-21-000007 |
| FY 2018Yearly · 2018-12-31 | Segment | Pet Nutrition | 2,388,000,000 | USD | 0000021665-21-000007 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.